ViaLase® is focused on fueling the practice of noninvasive interventional glaucoma with the introduction of the world's first femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) for open-angle glaucoma.
ViaLase is singularly focused on TRANSFORMing the way Glaucoma is managed
With a leadership team that has vast experience developing and commercializing the first femtosecond lasers for ophthalmic surgery for refractive and cataract patients; ViaLase is now bringing that expertise and innovation to glaucoma patients.
MEET OUR TEAM
With over 200 years of combined experience in ophthalmology, the ViaLase team is committed to fueling the practice of noninvasive interventional glaucoma.
ViaLase® products are currently not for sale, pending regulatory clearance.